Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Travere Therapeutics (TVTX) has a market cap of $1.32 billion USD. According to our data, Travere Therapeutics is ranked No.4611 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $1.32 B |
-12.70%
|
| Dec 31, 2024 | $1.52 B |
93.77%
|
| Dec 29, 2023 | $0.78 B |
-57.25%
|
| Dec 30, 2022 | $1.83 B |
-32.25%
|
| Dec 31, 2021 | $2.70 B |
13.89%
|
| Dec 31, 2020 | $2.37 B |
91.94%
|
| Dec 31, 2019 | $1.24 B |
-37.25%
|
| Dec 31, 2018 | $1.97 B |
7.40%
|
| Dec 29, 2017 | $1.83 B |
11.30%
|
| Dec 30, 2016 | $1.65 B |
-1.87%
|
| Dec 31, 2015 | $1.68 B |
57.60%
|
| Dec 31, 2014 | $1.07 B |
74.86%
|
| Dec 31, 2013 | $0.61 B |
108.96%
|
| Dec 31, 2012 | $0.29 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
USA
|
 Ultragenyx
RARE
|
$3.32 B |
0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
USA
|
 PTC Therapeutics
PTCT
|
$3.70 B |
-0.000 M
|
USA
|
 bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
Switzerland
|
 Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
 Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
USA
|
 Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
USA
|
| Market Cap | = | TVTX Stock Price | * | TVTX Shares Outstanding |
| = | $14.91 | * | 88.77 M | |
| = | $1.32 B |